Corvus Pharmaceuticals, Inc. (CRVS)

NASDAQ: CRVS · IEX Real-Time Price · USD
0.983
+0.018 (1.89%)
Aug 12, 2022 1:10 PM EDT - Market open

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Cash & Equivalents
63.4616.465.1539.245.115.054.1112.52
Short-Term Investments
5.9927.872.8375.444.95129.8590.280
Cash & Cash Equivalents
69.4544.2677.98114.690.06134.994.3912.52
Cash Growth
56.92%-43.24%-31.95%27.25%-33.24%42.92%654.06%-
Receivables
0.510000000
Other Current Assets
1.351.081.360.991.181.141.280.01
Total Current Assets
71.3145.3479.34115.5991.23136.0395.6612.53
Property, Plant & Equipment
3.642.553.792.182.673.251.850
Long-Term Investments
34.2737.23000000
Other Long-Term Assets
0.240.410.510.460.870.870.95-
Total Long-Term Assets
38.1440.194.32.643.544.122.80
Total Assets
109.4685.5383.65118.2394.78140.1598.4612.53
Accounts Payable
1.573.472.4523.451.91.580.06
Current Debt
1.051.080.8800000
Other Current Liabilities
7.087.66.95.035.524.041.52.62
Total Current Liabilities
9.6912.1510.237.038.975.943.072.67
Long-Term Debt
2.61.232.3100000
Other Long-Term Liabilities
0000.870.971.410.710
Total Long-Term Liabilities
2.61.232.310.870.971.410.710
Total Liabilities
12.2913.3812.547.99.947.353.782.68
Total Debt
3.652.313.1900000
Debt Growth
57.88%-27.54%------
Common Stock
361.67295.28288.23280.84208.41200.710.440
Retained Earnings
-266.38-223.14-217.15-170.47-123.53-67.87-31.5-0.16
Comprehensive Income
1.8700.03-0.03-0.04-0.04-0.050
Shareholders' Equity
97.1672.1571.11110.3484.84132.8-31.1-0.16
Total Liabilities and Equity
109.4685.5383.65118.2394.78140.15-27.322.52
Net Cash / Debt
65.841.9574.79114.690.06134.994.3912.52
Net Cash / Debt Growth
56.87%-43.91%-34.73%27.25%-33.24%42.92%654.06%-
Net Cash Per Share
1.571.422.554.174.408.75252.6173.51
Working Capital
61.6233.1969.12108.5682.27130.0992.599.86
Book Value Per Share
2.322.452.424.014.148.61-83.24-0.93
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).